• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

柯萨奇病毒/腺病毒受体与桥粒芯糖蛋白2在肺腺癌中的共表达:生物信息学与组织芯片的综合分析

Co-Expression of Coxsackievirus/Adenovirus Receptors and Desmoglein 2 in Lung Adenocarcinoma: A Comprehensive Analysis of Bioinformatics and Tissue Microarrays.

作者信息

Weng Ching-Fu, Huang Chi-Jung, Wu Mei-Hsuan, Lee Henry Hsin-Chung, Ling Thai-Yen

机构信息

Division of Pulmonary Medicine, Department of Internal Medicine, Hsinchu Cathay General Hospital, Hsinchu 300, Taiwan.

Department and Graduate Institute of Pharmacology, National Taiwan University, Taipei 100, Taiwan.

出版信息

J Clin Med. 2020 Nov 18;9(11):3693. doi: 10.3390/jcm9113693.

DOI:10.3390/jcm9113693
PMID:33217893
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7698609/
Abstract

INTRODUCTION

Coxsackievirus/adenovirus receptors (CARs) and desmoglein-2 (DSG2) are similar molecules to adenovirus-based vectors in the cell membrane. They have been found to be associated with lung epithelial cell tumorigenesis and can be useful markers in predicting survival outcome in lung adenocarcinoma (LUAD).

METHODS

A gene ontology enrichment analysis disclosed that DSG2 was highly correlated with CAR. Survival analysis was then performed on 262 samples from the Cancer Genome Atlas, forming "Stage 1A" or "Stage 1B". We therefore analyzed a tissue microarray (TMA) comprised of 108 lung samples and an immunohistochemical assay. Computer counting software was used to calculate the H-score of the immune intensity. Cox regression and Kaplan-Meier analyses were used to determine the prognostic value.

RESULTS

and genes are highly co-expressed in early stage LUAD and associated with significantly poorer survival ( = 0.0046). TMA also showed that CAR/DSG2 expressions were altered in lung cancer tissue. CAR in the TMA was correlated with proliferation, apoptosis, and epithelial-mesenchymal transition (EMT), while DSG2 was associated with proliferation only. The Kaplan-Meier survival analysis revealed that CAR, DSG2, or a co-expression of CAR/DSG2 was associated with poorer overall survival.

CONCLUSIONS

The co-expression of CAR/DSG2 predicted a worse overall survival in LUAD. CAR combined with DSG2 expression can predict prognosis.

摘要

引言

柯萨奇病毒/腺病毒受体(CARs)和桥粒芯糖蛋白-2(DSG2)是细胞膜中与腺病毒载体相似的分子。它们已被发现与肺上皮细胞肿瘤发生有关,并且在预测肺腺癌(LUAD)的生存结果方面可能是有用的标志物。

方法

基因本体富集分析显示DSG2与CAR高度相关。然后对来自癌症基因组图谱的262个样本进行生存分析,这些样本分为“1A期”或“1B期”。因此,我们分析了一个由108个肺样本组成的组织微阵列(TMA)并进行了免疫组织化学检测。使用计算机计数软件计算免疫强度的H评分。采用Cox回归和Kaplan-Meier分析来确定预后价值。

结果

和 基因在早期LUAD中高度共表达,并且与显著较差的生存率相关( = 0.0046)。TMA还显示肺癌组织中CAR/DSG2表达发生改变。TMA中的CAR与增殖、凋亡和上皮-间质转化(EMT)相关,而DSG2仅与增殖相关。Kaplan-Meier生存分析显示,CAR、DSG2或CAR/DSG2的共表达与较差的总生存率相关。

结论

CAR/DSG2的共表达预示LUAD患者的总生存率较差。CAR与DSG2表达相结合可预测预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d2/7698609/8009033aa3a9/jcm-09-03693-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d2/7698609/217b6d1a570a/jcm-09-03693-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d2/7698609/521e64be8039/jcm-09-03693-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d2/7698609/c90d9ca14ac7/jcm-09-03693-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d2/7698609/b1c2e640d148/jcm-09-03693-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d2/7698609/d36f36da5160/jcm-09-03693-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d2/7698609/3b6f8214a315/jcm-09-03693-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d2/7698609/8009033aa3a9/jcm-09-03693-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d2/7698609/217b6d1a570a/jcm-09-03693-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d2/7698609/521e64be8039/jcm-09-03693-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d2/7698609/c90d9ca14ac7/jcm-09-03693-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d2/7698609/b1c2e640d148/jcm-09-03693-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d2/7698609/d36f36da5160/jcm-09-03693-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d2/7698609/3b6f8214a315/jcm-09-03693-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d2/7698609/8009033aa3a9/jcm-09-03693-g007.jpg

相似文献

1
Co-Expression of Coxsackievirus/Adenovirus Receptors and Desmoglein 2 in Lung Adenocarcinoma: A Comprehensive Analysis of Bioinformatics and Tissue Microarrays.柯萨奇病毒/腺病毒受体与桥粒芯糖蛋白2在肺腺癌中的共表达:生物信息学与组织芯片的综合分析
J Clin Med. 2020 Nov 18;9(11):3693. doi: 10.3390/jcm9113693.
2
Upregulation of desmoglein 2 and its clinical value in lung adenocarcinoma: a comprehensive analysis by multiple bioinformatics methods.桥粒芯蛋白2在肺腺癌中的上调及其临床价值:基于多种生物信息学方法的综合分析
PeerJ. 2020 Feb 13;8:e8420. doi: 10.7717/peerj.8420. eCollection 2020.
3
DSG2 expression is correlated with poor prognosis and promotes early-stage cervical cancer.桥粒芯糖蛋白2(DSG2)的表达与预后不良相关,并促进早期宫颈癌发展。
Cancer Cell Int. 2020 Jun 3;20:206. doi: 10.1186/s12935-020-01292-x. eCollection 2020.
4
Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2.桥粒芯糖蛋白-2在非小细胞肺癌组织中过表达,其表达下调通过调节p27和细胞周期蛋白依赖性激酶2抑制非小细胞肺癌生长。
J Cancer Res Clin Oncol. 2017 Jan;143(1):59-69. doi: 10.1007/s00432-016-2250-0. Epub 2016 Sep 14.
5
DSG2 expression is low in colon cancer and correlates with poor survival.DSG2 表达在结肠癌中较低,与不良预后相关。
BMC Gastroenterol. 2021 Jan 6;21(1):7. doi: 10.1186/s12876-020-01588-2.
6
Desmoglein-2 overexpression predicts poor prognosis in hepatocellular carcinoma patients.桥粒芯糖蛋白 2 过表达预示肝癌患者预后不良。
Eur Rev Med Pharmacol Sci. 2018 Sep;22(17):5481-5489. doi: 10.26355/eurrev_201809_15808.
7
A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies.一项通过机器学习策略确定肺腺癌新预后预测模型的大型队列研究。
BMC Cancer. 2019 Sep 5;19(1):886. doi: 10.1186/s12885-019-6101-7.
8
Desmoglein-2 as a prognostic and biomarker in ovarian cancer.桥粒芯糖蛋白 2 作为卵巢癌的预后和生物标志物。
Cancer Biol Ther. 2020 Dec 1;21(12):1154-1162. doi: 10.1080/15384047.2020.1843323. Epub 2020 Nov 20.
9
Elevated FAM83A expression predicts poorer clincal outcome in lung adenocarcinoma.FAM83A 表达水平升高预示肺腺癌患者临床预后不良。
Cancer Biomark. 2019;26(3):367-373. doi: 10.3233/CBM-190520.
10
Identification of a novel glycolysis-related gene signature that can predict the survival of patients with lung adenocarcinoma.鉴定一种新型的糖酵解相关基因特征,可以预测肺腺癌患者的生存情况。
Cell Cycle. 2019 Mar;18(5):568-579. doi: 10.1080/15384101.2019.1578146. Epub 2019 Feb 17.

引用本文的文献

1
SPP1 mRNA Expression Is Associated with M2 Macrophage Infiltration and Poor Prognosis in Triple-Negative Breast Cancer.SPP1信使核糖核酸表达与三阴性乳腺癌中M2巨噬细胞浸润及不良预后相关。
Curr Issues Mol Biol. 2024 Nov 25;46(12):13499-13513. doi: 10.3390/cimb46120806.
2
Fluorescence-guided assessment of bone and soft-tissue sarcomas for predicting the efficacy of telomerase-specific oncolytic adenovirus.荧光引导评估骨和软组织肉瘤以预测端粒酶特异性溶瘤腺病毒的疗效。
PLoS One. 2024 Feb 20;19(2):e0298292. doi: 10.1371/journal.pone.0298292. eCollection 2024.
3
Desmoglein-2 as a cancer modulator: friend or foe?

本文引用的文献

1
A comprehensive analysis of metabolomics and transcriptomics in non-small cell lung cancer.非小细胞肺癌的代谢组学和转录组学综合分析。
PLoS One. 2020 May 6;15(5):e0232272. doi: 10.1371/journal.pone.0232272. eCollection 2020.
2
Upregulation of desmoglein 2 and its clinical value in lung adenocarcinoma: a comprehensive analysis by multiple bioinformatics methods.桥粒芯蛋白2在肺腺癌中的上调及其临床价值:基于多种生物信息学方法的综合分析
PeerJ. 2020 Feb 13;8:e8420. doi: 10.7717/peerj.8420. eCollection 2020.
3
Enhancement of Cutaneous Wound Healing by Dsg2 Augmentation of uPAR Secretion.
桥粒芯糖蛋白-2作为癌症调节因子:是友还是敌?
Front Oncol. 2023 Dec 22;13:1327478. doi: 10.3389/fonc.2023.1327478. eCollection 2023.
通过 Dsg2 增强 uPAR 分泌增强皮肤伤口愈合。
J Invest Dermatol. 2018 Nov;138(11):2470-2479. doi: 10.1016/j.jid.2018.04.024. Epub 2018 May 9.
4
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
5
Quantitative proteomics analysis of mitochondrial proteins in lung adenocarcinomas and normal lung tissue using iTRAQ and tandem mass spectrometry.使用iTRAQ和串联质谱对肺腺癌和正常肺组织中线粒体蛋白质进行定量蛋白质组学分析。
Am J Transl Res. 2017 Sep 15;9(9):3918-3934. eCollection 2017.
6
Upregulation of Coxsackie Adenovirus Receptor Sensitizes Cisplatin-Resistant Lung Cancer Cells to CRAd-Induced Inhibition.柯萨奇腺病毒受体上调使顺铂耐药肺癌细胞对CRAd诱导的抑制敏感。
J Cancer. 2017 May 12;8(8):1425-1432. doi: 10.7150/jca.18371. eCollection 2017.
7
Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2.桥粒芯糖蛋白-2在非小细胞肺癌组织中过表达,其表达下调通过调节p27和细胞周期蛋白依赖性激酶2抑制非小细胞肺癌生长。
J Cancer Res Clin Oncol. 2017 Jan;143(1):59-69. doi: 10.1007/s00432-016-2250-0. Epub 2016 Sep 14.
8
Desmoglein 2 promotes vasculogenic mimicry in melanoma and is associated with poor clinical outcome.桥粒芯糖蛋白2促进黑色素瘤的血管生成拟态,并与不良临床预后相关。
Oncotarget. 2016 Jul 19;7(29):46492-46508. doi: 10.18632/oncotarget.10216.
9
[Changes of 2015 WHO Histological Classification of Lung Cancer 
and the Clinical Significance].[2015年世界卫生组织肺癌组织学分类的变化及临床意义]
Zhongguo Fei Ai Za Zhi. 2016 Jun 20;19(6):332-6. doi: 10.3779/j.issn.1009-3419.2016.06.06.
10
Adenovirus vector infection of non-small-cell lung cancer cells is a trigger for multi-drug resistance mediated by P-glycoprotein.
Biochem Biophys Res Commun. 2016 Aug 5;476(4):183-187. doi: 10.1016/j.bbrc.2016.05.070. Epub 2016 Jun 7.